Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Dominik Koeditz - (Author)
  • Juergen Frensch - (Author)
  • Martin Bierbaum - (Author)
  • Nils-Henning Ness - , Department of Neurology (Author)
  • Benjamin Ettle - (Author)
  • Umakanth Vudumula - (Author)
  • Kapil Gudala - (Author)
  • Nicholas Adlard - (Author)
  • Santosh Tiwari - (Author)
  • Tjalf Ziemssen - , Department of Neurology (Author)

Details

Original languageEnglish
JournalMultiple sclerosis journal - experimental, translational and clinical
Publication statusPublished - Jan 2022
Peer-reviewedYes

External IDs

Scopus 85127255646